Brian Moran, MD, discusses focal brachytherapy, stereotactic transperineal prostate biopsy (STPB), and other recent technological advances for the management of prostate cancer.

Keywords: focal brachytherapy, stereotactic transperineal prostate biopsy

 

Prostate Brachytherapy Summary

Brian Moran, MD, discusses focal brachytherapy, stereotactic transperineal prostate biopsy (STPB), and other recent technological advances for the management of prostate cancer. Following his presentation, he and E. David Crawford, MD, provide a Q&A discourse on the subject.

ABOUT THE AUTHOR

+ posts

Brian J. Moran, MD, was the Medical Director of the Chicago Prostate Cancer Center, which he helped found in 1997. He was also the Director of Radiation Oncology at Duly Health and Care. He performed prostate seed implants since 1994. Dr. Moran graduated from the of Loyola Stritch School of Medicine, where he also completed his residency. He was board-certified by the American Board of Radiology. An experienced practitioner of prostate brachytherapy, Dr. Moran performed thousands of prostate seed implants and proctored physicians all over the United States and the world, including in Korea, Europe, and Hong Kong. Dr. Moran was a member of multiple specialty societies, including the American Society of Therapeutic Radiology and Oncology, the American College of Radiology, and the American Brachytherapy Society. Dr. Moran placed an emphasis on quality of life issues and long-term outcomes for prostate cancer patients. His passion for these issues was evident Dr. Moran was a frequent speaker at professional meetings, and authored numerous publications in medical journals and textbooks.